Mild and Moderate Aortic Regurgitation: Risk Factors for Progress and Outcome

Not yet recruitingOBSERVATIONAL

Enrollment

35,000

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions

Aortic Regurgitation

Trial Locations (1)

Västmanlands sjukhus Västerås, Västerås

All Listed Sponsors

collaborator

Region Västmanland

OTHER

lead

Uppsala University

OTHER

NCT07104968 - Mild and Moderate Aortic Regurgitation: Risk Factors for Progress and Outcome | Biotech Hunter | Biotech Hunter